Search clinical trials for: Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant

Total 477201 results

Roseli Shavitt
University of Pernambuco

Completed

Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder. (SMART)

Obsessive-Compulsive Disorder

Brazil
Massachusetts General Hospital
Robert Wood Johnson Foundation

Terminated

Pilot Study of Bupropion for Smoking Cessation in Postpartum Non-breastfeeding Women

Tobacco Use Disorder

United States
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Fluoxetine HCL 40 mg Capsules Under Fasting Conditions

Healthy

United States
Fondo Nacional de Desarrollo Científico y Tecnológico...

Completed

A Randomized Clinical Trial for Depressed Mothers at Primary Care Level (DMH)

Depression

Chile
University of Maryland, Baltimore
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)

Type 1 Diabetes | Hypoglycemia Associated Autonomic Failure

United States
GlaxoSmithKline

Completed

Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants

Anxiety Disorders

Mexico
Axsome Therapeutics, Inc.

Completed

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder (STRIDE-1)

Treatment Resistant Major Depressive Disorder

United States
Milton S. Hershey Medical Center

Withdrawn

Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19)

Covid19

United States
University of Minnesota

Completed

An Adaptive Treatment Strategy for Adolescent Depression-Continuation (PTAD GIA)

Adolescent Depression

United States
University of California, Los Angeles
City of Hope Medical Center

Withdrawn

Fluoxetine Prevention Trial

Cognitive Dysfunction

United States
Rio de Janeiro State University

Completed

Hot Flash as a Marker of Cardiovascular Risk in Recent Postmenopause: Effects of Non-hormonal Treatments

Endothelial Dysfunction | Cardiovascular Risk Factor | Postmenopausal Flushing

Brazil
National Institute on Drug Abuse (NIDA)

Completed

A Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder

Bipolar Disorder

United States
Eli Lilly and Company

Completed

A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing

Major Depressive Disorder

Japan
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Completed

Light, Ion, and Fluoxetine Efficacy (LIFE) in Depression

Major Depressive Disorder (MDD)

Canada
GlaxoSmithKline

Completed

A Local Register Study For Major Depression Of Paroxetine Controlled Release

Depressive Disorder, Major | Major Depressive Disorder (MDD)

China
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder

Major Depressive Disorder

United States
Portland VA Medical Center
GlaxoSmithKline; Schering-Plough

Completed

Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine

Major Depression
National Institute on Drug Abuse (NIDA)

Completed

Phase 2, Double-Blind, Placebo-Controlled Trial of Bupropion for Methamphetamine Dependence

Methamphetamine Dependence

United States
National Institute on Drug Abuse (NIDA)
University of California, Los Angeles

Unknown

Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1

Amphetamine-Related Disorders

United States
Teva Pharmaceuticals USA

Completed

Paroxetine Hydrochloride 40 mg Tablets Under Fasting Conditions

Healthy

Canada
Baystate Medical Center

Not yet recruiting

Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac Surgery (MINA)

Atrial Fibrillation

United States
WakeMed Health and Hospitals
Helios Cardio Inc

Completed

Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone (CAMP POAF)

Post Operative Atrial Fibrillation

United States
Sanofi

Completed

Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death (ALPHEE)

Ventricular Arrhythmia | Arrhythmia Prophylaxis

Netherlands, Spain, Belgium, Japan, Finland, Chile, Australia, United States, Argentina, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Mexico, Norway, Poland, Portugal, Russian Federation, Slovakia, South Africa and more
Abbott Medical Devices

Terminated

Pulmonary Vein Ablation Versus Amiodarone in the Elderly (PAVANE)

Atrial Fibrillation

Netherlands
University Medical Center Groningen

Completed

Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation (WISDOM)

Persistent Atrial Fibrillation

Netherlands
First Teaching Hospital of Tianjin University of...
Beijing Hospital of Traditional Chinese Medicine; State Administration of Traditional... and other collaborators

Completed

Acupuncture for Ischemic Post-stroke Depression

Post-stroke Depression

China
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Craving, Binge Eating and Obesity

Obesity | Binge Eating Disorder

United States
University of Alabama at Birmingham
National Cancer Institute (NCI)

Completed

Integrated Smoking Cessation Treatment for Low Income Community Corrections

Smoking Cessation

United States
National Institute on Drug Abuse (NIDA)

Completed

Maintaining Abstinence in Chronic Cigarette Smokers - 1

Tobacco Use Disorder

United States
North Dakota State University
Neuropsychiatric Research Institute, Fargo, North Dakota

Completed

A Comparison of Sustained and Extended Release Bupropion Following Bariatric Surgery

Roux en Y Gastric Bypass

United States
Emory University

Completed

Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C

Depression | Hepatitis C | Interferon-alpha Associated Side Effects
Boehringer Ingelheim

Completed

The Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion in Healthy Male Volunteers

Healthy

Germany
GlaxoSmithKline

Withdrawn

Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients

Depressive Disorder
Uma Rao
National Institute of Mental Health (NIMH)

Unknown

Hormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With Depression

Depression

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Framing Messages for Smoking Cessation With Bupropion - 6

Tobacco Use Disorder

United States
HaEmek Medical Center, Israel

Terminated

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

Chemotherapy | Breast Cancer, Metastatic

Israel
Emory University

Terminated

Comparison of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Depression

Major Depressive Disorder

United States
Emory University
National Institute of Mental Health (NIMH)

Completed

Neural Circuits in Women With Abuse and Posttraumatic Stress Disorder

PTSD

United States
St. Luke's-Roosevelt Hospital Center
GlaxoSmithKline

Completed

Wellbutrin XL for Dysthymic Disorder

Dysthymic Disorder

United States
Mark Eisenberg
Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...

Completed

Zyban as an Effective Smoking Cessation Aid for Patients Following an Acute Coronary Syndrome: The ZESCA Trial (ZESCA)

Myocardial Infarction | Smoking | Acute Coronary Syndrome

Canada, United States, Bangladesh, India, Iran, Islamic Republic of, Pakistan, Tunisia
National Institute of Mental Health (NIMH)
University of Oregon; University of Maryland; University of Minnesota

Recruiting

Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

Anxiety Disorders | Major Depressive Disorder

United States
University of Minnesota
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Stepped Care Versus Best Available Care for Bulimia Nervosa

Eating Disorders

United States
GlaxoSmithKline

Completed

A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects

Depressive Disorder

China
GlaxoSmithKline

Completed

Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects

Depressive Disorder

China
National Institute on Drug Abuse (NIDA)

Terminated

Efficacy and Safety of Bupropion for Treatment of Adolescent Smoking

Tobacco Dependence

United States
US Department of Veterans Affairs
Emory University

Withdrawn

Early Intervention for Post Traumatic Stress Disorder (PTSD)

Post-Traumatic Stress Disorders
Duke University
Massachusetts General Hospital; GlaxoSmithKline

Completed

Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy

Stress Disorders, Post-Traumatic

United States
Massachusetts General Hospital

Completed

Efficacy Of Bupropion For Attention Deficit Hyperactivity Disorder (ADHD) In Adults

Attention Deficit Hyperactivity Disorder (ADHD) | Substance Use Disorder (SUD)
Massachusetts General Hospital

Terminated

Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder

Depression | Bipolar Disorder

United States
GlaxoSmithKline

Completed

Effects of Antidepressants on Sexual Functioning

Major Depressive Disorder (MDD)

United States

Search clinical trials for: Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations